Australia
Modalis TMS, established in 2019 in Perth, Australia, represents a significant player in the Health Care and Health and Wellness industry through its innovative use of Transcranial Magnetic Stimulation (TMS). The company positions itself as Western Australia's trusted provider for non-invasive MRI-guided TMS, targeting psychiatric conditions such as depression, OCD, and PTSD, as well as pain management and rehabilitation.
With an emphasis on accessibility, Modalis TMS offers minimal waiting times across various locations in the metro area. Their TMS therapy boasts higher success rates and a superior safety profile compared to traditional treatments, earning acclaim for being drug-free and effective even in refractory cases.
The company also embarks on educational initiatives through the WA TMS Training Program, developed in collaboration with the University of Western Australia and the Perron Institute. This reflects their commitment to advancing TMS knowledge among health practitioners. Currently, Modalis TMS has not disclosed any recent funding rounds or investors.
